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Aim
The aim of this study was to analyze the differences in
patient demographics as well as in the relative incidence
and outcome of childhood cancers, associated with the
HIV infection.
Material and methods
A retrospective comparative study of two series of children
with malignant disease, one with HIV one without, was
carried out. The former series consisted of 99 African
children with cancer and HIV, consecutively admitted at
Tygerberg Children’s Hospital, Cape Town and Universi-
tas Hospital, Bloemfontein, from 1995 to 2010. The latter
series was formed of 570 African children with malignant
diseases, not infected with HIV, consecutively admitted at
the 2 hospitals, from January 2002 to December 2010.
Variables studied were age, sex ratio, distribution of
various malignancies, length of follow-up, treatment aban-
donment and mortality.
Results
The HIV positive children tended to be younger at diag-
nosis. The male/female ratio was slightly over 2 to 1 in
the HIV positive group, while in the control group the
sex ratio approached 1:1. Kaposi sarcoma was seen
exclusively in the HIV positive series.
The death rate was 50.5% in the HIV positive children
(versus 40.8% in HIV negative) but the difference is not
significant.
When subgroups with matched cancers were com-
pared, children infected with HIV had a significantly
higher risk to die of drug-induced toxicity (relative risk
29.2, 95% confidence interval 3.7-225.8); only 26% of the
HIV-positive children survived, compared with 51.2% in
those not HIV infected (p=0.02).
Conclusions
The infection with HIV increases the risk for Kaposi
sarcoma, for death due to cytostatic toxicity as well as
the overall risk of death in children with cancer.
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